Laurence Rodriguez
Chief Executive Officer at GENSIGHT BIOLOGICS S.A.
Profile
Laurence Rodriguez is currently the Chief Executive Officer & Director at Gensight Biologics SA. Previously, she worked as the Head of Rare Diseases & Rare Blood Disorders at Genzyme Therapeutics Ltd.
Ms. Rodriguez completed her undergraduate and graduate degrees at Sciences Po.
Laurence Rodriguez active positions
| Companies | Position | Start |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Chief Executive Officer | 2023-12-20 |
Former positions of Laurence Rodriguez
| Companies | Position | End |
|---|---|---|
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Training of Laurence Rodriguez
| Sciences Po | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Private companies | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Laurence Rodriguez
